Dr.Med. Martin Leixnering Data, Technology Stack, and Enterprise Applications
IaaS
Vendor
Old Product
New Product
Category
Market
VAR/SI
When
Live
Microsoft Legacy Microsoft Azure Cloud Services Application Hosting and Computing Services IaaS n/a 2019 2019
Content Delivery Network IaaS 2020 2020
Collaboration
Vendor
Old Product
New Product
Category
Market
VAR/SI
When
Live
Microsoft Legacy Microsoft 365 Collaboration Collaboration n/a 2019 2019
IT Decision Makers and Key Stakeholders at Dr.Med. Martin Leixnering
First Name Last Name Title Function Department Email Phone
No data found
Apps Being Evaluated by Dr.Med. Martin Leixnering Executives
Date Company Status Vendor Product Category Market
No data found
FAQ - APPS RUN THE WORLD Dr.Med. Martin Leixnering Technographics

Dr.Med. Martin Leixnering is a Healthcare organization based in Austria, with around 1 employees and annual revenues of $1.0 million.

Dr.Med. Martin Leixnering operates a diverse technology stack with applications such as Microsoft Azure Cloud Services and Microsoft 365, covering areas like Application Hosting and Computing Services and Collaboration.

Dr.Med. Martin Leixnering has invested in cloud applications and AI-driven platforms to optimize efficiency and growth, collaborating with vendors such as Microsoft.

Dr.Med. Martin Leixnering recently adopted applications including Cloudflare CDN in 2020, Microsoft Azure Cloud Services in 2019 and Microsoft 365 in 2019, highlighting its ongoing modernization strategy.

APPS RUN THE WORLD maintains an up-to-date database of Dr.Med. Martin Leixnering’s key decision makers and IT executives, available to Premium subscribers.

Our research team continuously updates Dr.Med. Martin Leixnering’s profile with verified software purchases, vendor relationships, and digital initiatives identified from public and proprietary sources.

Subscribe to APPS RUN THE WORLD to access the complete Dr.Med. Martin Leixnering technographics profile, including detailed breakdowns by category, vendor, and IT decision makers.